The Canadian COVID‑19 Funded Research Database

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 181 through 190 of 353 results (Download Results)

Show results per page

SARS-CoV-2 virus infection in vaccinated vulnerable populations and the potential for variant emergence

Kelvin, Alyson A | University of Saskatchewan | Operating Grant | $499,900

CIHR Saskatchewan 2021

COVID-19 Variant Supplement – Development and implementation of rapid metagenomic sequencing coupled with isothermal amplification point of care testing for viral diagnostics

Pillai, Dylan R | The University of Calgary | Operating Grant | $50,000

CIHR Alberta 2021

Canadian COVID‑19 Emergency Department Rapid Response Network: Determining Real-World Vaccine Effectiveness and Duration of Protection Against Variants of Concern

Brooks, Steven C | Queen's University | Operating Grant | $496,134

CIHR Ontario 2021

A double blind randomized trial of low-dose naltrexone for post-covid fatigue syndrome

Nacul, Luis | B.C. Women's Hospital | Operating Grant | $742,331

CIHR British Columbia 2021

COVID19 persistent symptomatology: an investigation of the metabolomic and proteomic underpinning

Corbeil, Jacques | Université Laval | Operating Grant | $394,000

CIHR Quebec 2021

COVID-19 Variant Network – Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID‑19 through mechanism-based drug repurposing and combinatorial organoid screening.

Cherkasov, Artem | University of British Columbia | Operating Grant | $90,000

CIHR British Columbia 2021

Variants of concern: escape from infection- and vaccination-induced immunity in older adults

Gingras, Anne-Claude | Sinai Health System | Operating Grant | $496,159

CIHR Ontario 2021

COVID-19 Variant Supplement – Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2

Leclerc, Denis | CHU de Québec | Operating Grant | $50,000

CIHR Quebec 2021

Mitigating COVID‑19 variant spread by leveraging social psychological and neurobiological markers to optimize public health communications during the first vaccine rollout.

Hall, Peter A | University of Waterloo | Operating Grant | $496,565

CIHR Ontario 2021

COVID-19 Variant Supplement – The COVID‑19 Pandemic Among Sexual and Gender Marginalized Populations in Canada: Physical Distancing Impacts, SARS-CoV-2 Seroprevalence, and Health and Wellness Needs

Lachowsky, Nathan J | University of Victoria | Operating Grant | $50,000

CIHR British Columbia 2021

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

SARS-CoV-2 virus infection in vaccinated vulnerable populations and the potential for variant emergence

COVID-19 Variant Supplement – Development and implementation of rapid metagenomic sequencing coupled with isothermal amplification point of care testing for viral diagnostics

Canadian COVID‑19 Emergency Department Rapid Response Network: Determining Real-World Vaccine Effectiveness and Duration of Protection Against Variants of Concern

A double blind randomized trial of low-dose naltrexone for post-covid fatigue syndrome

COVID19 persistent symptomatology: an investigation of the metabolomic and proteomic underpinning

COVID-19 Variant Network – Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID‑19 through mechanism-based drug repurposing and combinatorial organoid screening.

Variants of concern: escape from infection- and vaccination-induced immunity in older adults

COVID-19 Variant Supplement – Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2

Mitigating COVID‑19 variant spread by leveraging social psychological and neurobiological markers to optimize public health communications during the first vaccine rollout.

COVID-19 Variant Supplement – The COVID‑19 Pandemic Among Sexual and Gender Marginalized Populations in Canada: Physical Distancing Impacts, SARS-CoV-2 Seroprevalence, and Health and Wellness Needs